| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5658254 | Gastroenterology | 2017 | 33 Pages |
Abstract
In an analysis of 999 patients with a diagnosis of colon cancer, we associated statin with reduced risk of death from any cause or from cancer. The benefit of statin use is greater for patients whose tumors have intact BMP signaling, independent of KRAS mutation status. Randomized controlled trials are required to confirm these results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Philip W. Voorneveld, Marlies S. Reimers, Esther Bastiaannet, Rutger J. Jacobs, Ronald van Eijk, Marjolein M.J. Zanders, Ron M.C. Herings, Myrthe P.P. van Herk-Sukel, Liudmila L. Kodach, Tom van Wezel, Peter J.K. Kuppen, Hans Morreau,